[The Prognosis Assessment Value of Interim 18F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma].
Saved in:
| Title: | [The Prognosis Assessment Value of Interim 18F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma]. |
|---|---|
| Authors: | Peng XJ; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Kou Y; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Yu SS; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Yao YT; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Jiang XM; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., You JH; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China., Zhang ZH; Department of Medical Oncology, Sichuan Cancer Hospital ＆ Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Chen SR; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China., Jiang X; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China; Institute of Isotopes, China Institute of Atomic Energy, Beijing 102413, China., Cheng ZZ; Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, Sichuan Province, China; PET/CT Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China. E-mail: chengzhuzhong@163.com. |
| Source: | Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Oct; Vol. 30 (5), pp. 1440-1445. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
